$2.91
0.031.04%
At Close: -
$2.92
0.01000.34%
After Hours: 4:45 PM EDT
15 minutes delayed
Comments
Loading...
Allogene Therapeutics (ALLO) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAllogene Therapeutics (NASDAQ:ALLO) Stock Quotes, Forecast and News Summary
Allogene Therapeutics Stock (NASDAQ: ALLO) stock price, news, charts, stock research, profile.
| Open | $3.02 |
| Close | $2.91 |
| Volume / Avg. | 4.74M / 2.45M |
| Day Range | $2.86 - $3.07 |
| 52 Wk Range | 2.01 - 5.78 |
| Market Cap | $610.61M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 57 |
| Short Interest | 26.21% |
| Days to Cover | 22.96 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Allogene Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Allogene Therapeutics (ALLO) stock?
You can purchase shares of Allogene Therapeutics (NASDAQ:ALLO) through any online brokerage.
Who are Allogene Therapeutics (ALLO) competitors?
Other companies in Allogene Therapeutics’s space includes: Humacyte (NASDAQ:HUMA), Celcuity (NASDAQ:CELC), Pharming (NASDAQ:PHAR), Mesoblast (NASDAQ:MESO) and Opthea (NASDAQ:OPT).
What is the forecast, or price target, for Allogene Therapeutics (ALLO) stock?
Allogene Therapeutics has a consensus price target of $13.42.
What is the current price for Allogene Therapeutics (ALLO)?
The stock price for Allogene Therapeutics (NASDAQ: ALLO) is $2.92 last updated September 19, 2024 at 4:45 PM EDT.
Does Allogene Therapeutics (ALLO) pay a dividend?
There are no upcoming dividends for Allogene Therapeutics.
When is Allogene Therapeutics (NASDAQ:ALLO) reporting earnings?
Allogene Therapeutics’s Q3 earnings are confirmed for Thursday, October 31, 2024.
Is Allogene Therapeutics (ALLO) going to split?
There is no upcoming split for Allogene Therapeutics.
What sector and industry does Allogene Therapeutics (ALLO) operate in?
Allogene Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.